An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for ...

GORTEC, known as Head and Neck Radiation Oncology Group, today announced that the randomized Phase 3 NIVOPOSTOP GORTEC ...

PF-07921585 is under clinical development by Pfizer and currently in Phase I for Metastatic Colorectal Cancer.

CX-801 is under clinical development by CytomX Therapeutics and currently in Phase I for Metastatic Melanoma. According to GlobalData, Phase I drugs for Metastatic Melanoma have an 81% phase ...

A Medical University of South Carolina Hollings Cancer Center researcher is exploring new ways to improve treatment options for kidney cancer patients.

While tobacco and alcohol are known to increase the risk of head and neck cancer, new research has found the amount of coffee ...

The Jimmy Carter drug introduced the world to cancer immunotherapy, a treatment that differs from chemotherapy. Carter was ...

Opdivo Qvantig is approved for solid tumors, including melanoma, renal cell carcinoma, and non-small cell lung cancer. The ...

Pooled analysis of numerous studies suggests a potentially protective effect. In a recent analysis of data from more than a dozen studies, coffee and tea consumption was linked with lower risks of ...

In the latest statistical salvo of an ongoing debate, people who consumed more than four cups of caffeinated coffee daily had ...

In an analysis of data from more than a dozen studies, coffee and tea consumption was linked with lower risks of developing head and neck cancer, including cancers of the mouth and throat.